European consortium to improve healthcare through cell-based interceptive medicine
Researchers, clinicians, industry leaders and policy makers are united by a vision of how to revolutionise healthcare. Niko Beerenwinkel, head of the Computational Biology Group, is a member of this LifeTime consortium which presents in Nature a detailed roadmap of how to improve European healthcare through cell-based interceptive medicine.
Find external page original article in Nature Perspective (open access); find external page LifeTime Strategic Research Agenda.
More information about the external page European LifeTime initiative.
Learn about the Computational Biology Group led by Niko Beerenwinkel.